Prior to joining Roche Diagnostics, Mr. Sheives was the Vice President, Reimbursement & Regulatory Policy at the American Clinical Laboratory Association (ACLA), a Washington, D.C.-based association that represents the nation’s leading clinical laboratories on federal and state government policies impacting the industry. Its diverse membership consists of national, regional, esoteric, hospital and nursing home laboratories that perform millions of tests each year to the benefit of patients. With a background in molecular biology, regulatory law, and reimbursement counseling, Mr. Sheives has represented companies throughout the spectrum of biotechnology.
Prior to ACLA, Mr. Sheives was the Director of Diagnostics and Personalized Medicine Policy at the Biotechnology Industry Organization (BIO). Before BIO, Mr. Sheives practiced in two large, international law firms as a legal associate in the areas of FDA and reimbursement law, and prior to that a regulatory science advisor. He holds a J.D. from the Georgetown University Law Center, a M.S. in Molecular and Cellular Biology from the University of Texas Southwestern Medical Center at Dallas, and a B.S. in Microbiology from the University of Texas at Arlington.